McDermott and Bull executive Search

Other News

Texas Cardiac Arrhythmia Institute leader participates in clinical trial for world’s first artificial intelligence technology for complex cardiac arrhythmia procedures

AUSTIN, Texas, July 22, 2021 /PRNewswire/ — The leader of the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center recently led a clinical study to evaluate the world’s first data-driven artificial intelligence (AI) platform for cardiac electrophysiology (EP) procedures. Andrea Natale, M.D., F.H.R.S., F.A.C.C., F.E.S.C., cardiac electrophysiologist and executive medical director of TCAI, conducted the […]

Galaxy Medical’s ECLIPSE-AF Study 90 Day Remapping Results to be Featured at the 2021 Stanford Biodesign New Arrhythmia Technologies Retreat

SAN CARLOS, Calif., July 22, 2021 /PRNewswire/ — Galaxy Medical announced today that the 90 day remapping results of its ECLIPSE-AF study will be featured at the 2021 Stanford Biodesign New Arrhythmia Technologies Retreat on July 27th.  Ante Anić, M.D., Electrophysiology Laboratory Director at University Clinical Hospital in Split, Croatia, and primary investigator of […]

JanOne Selects CPC Clinical Research as Trial Manager for Phase 2b Study of JAN101 for Peripheral Artery Disease Patients

CPC to Manage Planning, Organization, and Day-to-Day Execution of the Trial LAS VEGAS, July 22, 2021 /PRNewswire/ — JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced that it has selected CPC Clinical Research (CPC), a full-service academic research organization […]

Implicity Launches a Solution to Improve Remote Monitoring of Heart Failure Patients

Company Signs Commercial Agreement with Bayer HealthCare SAS France to Accelerate Global Adoption and Improve Quality of Care for Heart Failure Patients Worldwide PARIS and CAMBRIDGE, Mass., July 22, 2021 /PRNewswire/ — Implicity, a leader in remote patient monitoring software and cardiac data management solutions, announced the company is expanding its line of products and […]

PaceMate™ and UNC School of Medicine Advance Cardiac Research with Data Partnership

BRADENTON, Fla.–(BUSINESS WIRE)–PaceMate™, the leading digital healthcare company in compliant cardiac data management, is pleased to announce a new strategic data research partnership with electrophysiologists, cardiologists, and the department research team at the University of North Carolina School of Medicine. The unmatched breadth of cardiac device data collected via PaceMate™’s […]

Biospectal raises $ 4.3 million in seed funds

–  Biospectal raises $ 4.3 million in seed funds led by digital health investor SeedLink The remote monitoring and patient biosensing company will use the investment to scale its OptiBP ™ blood pressure measurement and monitoring product and operations worldwide; Renowned Interventional Cardiologist and Inventor, Dr. Fred St. Goar , MD, and Tim Juergens , of […]

Axon Therapies Announces Chad Hoskins As Chief Executive Officer

Seasoned medical device executive prepares for commercialization of innovative heart failure therapy SANTA CLARA, Calif., July 21, 2021 /PRNewswire/ — Axon Therapies, a private company focused on addressing a root cause of heart failure, today announced the appointment of seasoned medical device executive Chad Hoskins as Chief Executive Officr (CEO). Mr. Hoskins will lead […]

Cardiologs Unveils New Solution to Enable Use of Smartwatches for Remote Patient Monitoring

PARIS and BOSTON, July 21, 2021 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, today announced the launch of Cardiologs RPM – an innovative new solution that unlocks the potential of smartwatches for remote cardiac patient monitoring. Cardiologs will debut the new offering at the Heart Rhythm Society’s annual meeting, Heart Rhythm 2021 (Booth […]

BIOMODEX Technology Enables New Milestone in Interventional Cardiology

Physicians at Montreal Heart Institute used LAACS™ solution to simulate left atrial appendage occlusion, validating the company’s efforts to reduce surgical errors and improve outcomes BOSTON, July 21, 2021 /PRNewswire/ — BIOMODEX®, the leader in bio-realistic haptic simulators for patient-specific rehearsal and physician training, today announced that its LAACS™ (Left Atrial Appendage Closure System) solution […]

LEXEO Therapeutics Expands Cardiac Gene Therapy Pipeline with Acquisition of Stelios Therapeutics and its Gene Therapy Programs for Rare Cardiovascular Diseases

LEXEO obtains exclusive rights to three investigational AAV-mediated gene therapy programs for rare cardiac disorders, all of which have no existing disease-modifying treatments available Strategic acquisition expands LEXEO’s rare cardiac gene therapy pipeline making it one of the most extensive in the field NEW YORK, July 21, 2021 (GLOBE NEWSWIRE) […]